The share of U.S. startup investment going to biotech companies has hit the lowest level in more than 20 years, as an ever-growing proportion of funding goes to AI upstarts in other sectors. We take a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback